PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Annual Income Tax Expense (Benefit) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
  • Pacific Biosciences Of California, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Pacific Biosciences Of California, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$718K, a 93.3% increase year-over-year.
  • Pacific Biosciences Of California, Inc. annual Income Tax Expense (Benefit) for 2023 was -$11.4M.
  • Pacific Biosciences Of California, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$11.4M -$11.4M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $0 +$93.6M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$93.6M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.